tiprankstipranks
Trending News
More News >
BioLargo Inc (BLGO)
OTHER OTC:BLGO
US Market

BioLargo (BLGO) Income Statement

Compare
63 Followers

BioLargo Income Statement

Last quarter (Q1 2025), BioLargo's total revenue was $3.27M, a decrease of -31.32% from the same quarter last year. In Q1, BioLargo's net income was $-1.16M. See BioLargo’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 17.78M$ 12.23M$ 5.88M$ 2.53M$ 2.43M
Gross Profit
$ 7.85M$ 6.15M$ 2.86M$ 1.10M$ 1.23M
Operating Expenses
$ 12.18M$ 10.34M$ 7.98M$ 7.48M$ 8.67M
Depreciation and Amortization
$ 255.00K$ 0.00$ 45.00K$ 20.00K$ 58.00K
EBITDA
$ -4.06M$ -4.19M$ -5.10M$ -6.70M$ -7.83M
Operating Income
$ -4.33M$ -4.19M$ -5.12M$ -6.38M$ -7.45M
Other Income/Expenses
$ 1.93M$ -449.00K$ 61.00K$ -458.00K$ -2.12M
Pretax Income
$ -2.40M$ -4.63M$ -5.13M$ -6.89M$ -9.70M
Net Income
$ -2.40M$ -3.50M$ -4.50M$ -7.38M$ -10.47M
Per Share Metrics
Basic EPS
$ -0.01$ -0.01$ -0.02$ -0.03$ -0.05
Diluted EPS
$ -0.01$ -0.01$ -0.02$ -0.03$ -0.05
Weighted Average Shares Outstanding
298.12M 285.96M 268.30M 247.20M 195.99M
Weighted Average Shares Outstanding (Diluted)
298.12M 285.96M 268.30M 247.20M 195.99M
Currency in USD

BioLargo Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis